Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Journal of Nephrology|July 4, 2024
Bone mineral density assessment in patients with cystinuriaViola D'Ambrosio, Giovanna Capolongo, Chiara Caletti, et al.
Blood|February 10, 2025
17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized miceEnrica Federti, Domenico Mattoscio, Antonio Recchiuti, et al.
United European Gastroenterology Journal|November 9, 2019
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel diseaseLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
Tomography (Ann Arbor, Mich.)|May 23, 2023
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and PrognosisLucio Calandriello, Enrico De Lorenzis, Giuseppe Cicchetti, et al.
Clinical and Experimental Rheumatology|February 16, 2019
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEAFabiola Atzeni, Piercarlo Sarzi-Puttini, Marco Sebastiani, et al.
Rheumatology (Oxford, England)|May 16, 2020
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria Grazia Lazzaroni, et al.
Nature Communications|September 28, 2016
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritisStefano Alivernini, Mariola Kurowska-Stolarska, Barbara Tolusso, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world studyLaure Gossec, Stefan Siebert, Paul Bergmans, et al.
Seminars in Arthritis and Rheumatism|November 6, 2017
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritisFausto Salaffi, Marco Di Carlo, Florenzo Iannone, et al.
Arthritis Research & Therapy|June 23, 2023
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world studyLaure Gossec, Stefan Siebert, Paul Bergmans, et al.
Pageof 21